Active Pharmaceutical Ingredient API News and Research

RSS

Mallinckrodt’s net sales increase $540.2M to 7.2% in first quarter 2014

Mallinckrodt plc, a global specialty pharmaceutical and medical imaging business, today reported results for the first quarter of fiscal 2014, which ended December 27, 2013. The company also announced revised guidance for fiscal 2014.

6 Feb 2014

AACN invites nurses, other healthcare professionals to 2014 National Teaching Institute & Critical Care Exposition

The American Association of Critical-Care Nurses (AACN) invites nurses and other healthcare professionals who care for high acuity and critically ill patients and their families to its 2014 National Teaching Institute & Critical Care Exposition (NTI) in Denver, May 19-22, with preconferences May 17-18.

23 Jan 2014

A&D Medical releases secure, flexible platform to help people manage their health

For everyone from patients to quantified selfers, A&D Medical today announced the release of its next generation Wellness Connected®, a secure, flexible platform to help people increase physical activity and manage their health.

7 Jan 2014

ScinoPharm constructs Changshu plant in China

ScinoPharm today announced that the company has completed construction of its Changshu plant on a 16-acre (6.5-hectare) site.

12 Dec 2013

AB SCIEX launches IVD-MS Analyzer CE marked for general in vitro diagnostic use in Europe

Continuing to rapidly expand its presence in the clinical diagnostics field, AB SCIEX, a global leader in analytical technologies, today announced the launch of its AB SCIEX IVD-MS™ Analyzer CE marked for general in vitro diagnostic use in Europe.*

27 Nov 2013

TPI’s revenue decreases 8.1% to $14.8 million in first quarter fiscal year 2014

Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the first quarter fiscal year 2014.

15 Nov 2013

Orexigen Therapeutics reports net loss of $18.6 million in Q3 2013

Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced business and financial results for the third quarter ended September 30, 2013.

12 Nov 2013

Genovate, ScinoPharm to jointly develop new-generation oral Hepatitis B drug Livepro

Genovate Biotechnology Co. Ltd. and ScinoPharm Taiwan Ltd. announced today that they have jointly developed the highly potent oral generic drug Livepro (Entecavir), representing a new generation of drugs for the treatment of Hepatitis B. It is expected to be commercially available by the end of the year in Taiwan, accounting for more than NT$2 billion (US$70 million) worth of market opportunity.

11 Nov 2013

Mylan's revenues decrease 2% to $1.77B in third quarter 2013

Mylan Inc. today announced its financial results for the three and nine months ended September 30, 2013.

31 Oct 2013

Univar signs agreement with Swati Spentose to become exclusive distributor of Lidocaine products

Univar Inc., a leading global chemical distributor, announced today that it has entered into an agreement with Swati Spentose Pvt. Ltd. to become its exclusive distributor of Lidocaine products, including Lidocaine Base and Lidocaine HCl in the United States.

22 Oct 2013

Thomson Reuters adds Cortellis Clinical Trials Intelligence for drug discovery and development

The Intellectual Property & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, today announced the addition of Clinical Trials Intelligence to the Thomson Reuters CortellisTM suite, the industry's most comprehensive information solution for drug discovery and development.

19 Oct 2013

Perrigo Company and Teva Pharmaceutical launch generic equivalent to temozolomide

Teva Pharmaceutical Industries Ltd. and Perrigo Company today announced the launch of the generic equivalent to Temodar (temozolomide).

13 Aug 2013

FMC acquires all shares of Epax for $345 million

FMC Corporation today announced that it has acquired all of the shares of Epax Nutra Holding III AS (Norway) and Epax UK Holding III AS (United Kingdom) (together, "Epax"), a leading manufacturer of high purity, premium grade Omega-3 fatty acid concentrates that are used in nutraceuticals, pharmaceuticals and food.

24 Jul 2013

Tianyin Pharmaceutical provides further updates on Gingko Mihuan Oral Liquid

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today provided further updates on the business development of its flagship product: Gingko Mihuan Oral Liquid with the SFDA approval number: H20013079.

19 Jul 2013

Eleven Biotherapeutics reports positive results from EBI-005 Phase 1b/2a study in patients with DED

Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today positive topline clinical results from a 6-week randomized, double-masked, placebo-controlled Phase 1b/2a study of EBI-005 in patients with dry eye disease.

28 Jun 2013

Dassault Systèmes launches industry solution experience for pharmaceutical, biotech companies

Dassault Systèmes, the 3DEXPERIENCE Company, a world leader in 3D design, 3D Digital Mock Up and Product Lifecycle Management solutions, announced today the launch of a new industry solution experience for pharmaceutical and biotech companies, "Licensed to Cure for BioPharma."

27 Jun 2013

Highland Therapeutics subsidiary reports positive HLD-200 Phase-1 results in ADHD patients

Highland Therapeutics, Inc., a specialty pharmaceutical company based in the MaRS Discovery District in Toronto, today announced that its wholly owned subsidiary has generated positive Phase-1 results for HLD-200 - a novel formulation of methylphenidate being developed to treat the symptoms associated with Attention-Deficit/Hyperactivity Disorder.

25 Jun 2013

Powerful new mass spectrometry systems and solutions for life-science research, clinical research, pharma and applied markets announced by Bruker

At the 61st ASMS Conference on Mass Spectrometry and Allied Topics, Bruker today announced mass spectrometry-based product introductions for life-science and clinical research, for biotech/pharma/CRO customers, as well as for industrial and applied markets. The new mass spectrometry systems and solutions are designed to deliver confident analyses with dramatically enhanced resolution, sensitivity and precision.

10 Jun 2013

AB SCIEX launches 3200MD CE-IVDD series in Europe for in vitro diagnostic use

AB SCIEX, a global leader in analytical technologies, today announced the launch of the 3200MD CE-IVDD series for general in vitro diagnostic use in Europe.

20 May 2013

ScinoPharm Taiwan, Coland Holdings partner to develop generic oncological drugs for China

ScinoPharm Taiwan Ltd. and Coland Holdings Ltd. announced today that they have formed a strategic alliance to develop a series of generic oncological drugs for Mainland China.

10 May 2013